» Articles » PMID: 22452815

Steroid-like Signalling by Interferons: Making Sense of Specific Gene Activation by Cytokines

Overview
Journal Biochem J
Specialty Biochemistry
Date 2012 Mar 29
PMID 22452815
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Many cytokines, hormones and growth factors use the JAK (Janus kinase)/STAT (signal transducer and activator of transcription) pathway for cell signalling and specific gene activation. In the classical model, ligand is said to interact solely with the receptor extracellular domain, which triggers JAK activation of STATs at the receptor cytoplasmic domain. Activated STATs are then said to carry out nuclear events of specific gene activation. Given the limited number of STATs (seven) and the activation of the same STATs by cytokines with different functions, the mechanism of the specificity of their signalling is not obvious. Focusing on IFNγ (interferon γ), we have shown that ligand, receptor and activated JAKs are involved in nuclear events that are associated with specific gene activation, where the receptor subunit IFNGR1 (IFNγ receptor 1) functions as a transcription/co-transcription factor and the JAKs are involved in key epigenetic events. RTKs (receptor tyrosine kinases) such as EGFR [EGF (epidermal growth factor) receptor] and FGFR [FGF (fibroblast growth factor) receptor] also undergo nuclear translocation in association with their respective ligands. EGFR and FGFR, like IFNGR1, have been shown to function as transcription/co-transcription factors. The RTKs also regulate other kinases that have epigenetic effects. Our IFNγ model, as well as the RTKs EGFR and FGFR, have similarities to that of steroid receptor signalling. These systems consist of ligand-receptor-co-activator complexes at the genes that they activate. The co-activators consist of transcription factors and kinases, of which the latter play an important role in the associated epigenetics. It is our view that signalling by cytokines such as IFNγ is but a variation of specific gene activation by steroid hormones.

Citing Articles

Disparate viral pandemics from COVID19 to monkeypox and beyond: a simple, effective and universal therapeutic approach hiding in plain sight.

Johnson H, Ahmed C Front Immunol. 2023; 14:1208828.

PMID: 38106428 PMC: 10722180. DOI: 10.3389/fimmu.2023.1208828.


Identification of Key Biomarkers Associated with Immunogenic Cell Death and Their Regulatory Mechanisms in Severe Acute Pancreatitis Based on WGCNA and Machine Learning.

Wang Z, Liu J, Wang Y, Guo H, Li F, Cao Y Int J Mol Sci. 2023; 24(3).

PMID: 36769358 PMC: 9918120. DOI: 10.3390/ijms24033033.


Virus Infections and Host Metabolism-Can We Manage the Interactions?.

Sumbria D, Berber E, Mathayan M, Rouse B Front Immunol. 2021; 11:594963.

PMID: 33613518 PMC: 7887310. DOI: 10.3389/fimmu.2020.594963.


Noncanonical IFN Signaling, Steroids, and STATs: A Probable Role of V-ATPase.

Johnson H, Noon-Song E, Ahmed C Mediators Inflamm. 2019; 2019:4143604.

PMID: 31275057 PMC: 6558600. DOI: 10.1155/2019/4143604.


Noncanonical IFN Signaling: Mechanistic Linkage of Genetic and Epigenetic Events.

Johnson H, Ahmed C Mediators Inflamm. 2017; 2016:9564814.

PMID: 28077919 PMC: 5203919. DOI: 10.1155/2016/9564814.


References
1.
Bader T, Weitzerbin J . Nuclear accumulation of interferon gamma. Proc Natl Acad Sci U S A. 1994; 91(25):11831-5. PMC: 45329. DOI: 10.1073/pnas.91.25.11831. View

2.
Yang X, Pappu B, Nurieva R, Akimzhanov A, Kang H, Chung Y . T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 2008; 28(1):29-39. PMC: 2587175. DOI: 10.1016/j.immuni.2007.11.016. View

3.
Noon-Song E, Ahmed C, Dabelic R, Canton J, Johnson H . Controlling nuclear JAKs and STATs for specific gene activation by IFNγ. Biochem Biophys Res Commun. 2011; 410(3):648-53. PMC: 3148262. DOI: 10.1016/j.bbrc.2011.06.047. View

4.
Robertson A, Bilenky M, Tam A, Zhao Y, Zeng T, Thiessen N . Genome-wide relationship between histone H3 lysine 4 mono- and tri-methylation and transcription factor binding. Genome Res. 2008; 18(12):1906-17. PMC: 2593584. DOI: 10.1101/gr.078519.108. View

5.
McGeachy M, Chen Y, Tato C, Laurence A, Joyce-Shaikh B, Blumenschein W . The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol. 2009; 10(3):314-24. PMC: 2945605. DOI: 10.1038/ni.1698. View